Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 44 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT07116616
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- University of Alabama at Birmingham Hospital Birmingham, Alabama, United States
- UCSF San Francisco, California, United States
- Emory University Hospital Atlanta, Georgia, United States
- Mass General Brigham Boston, Massachusetts, United States
NCT05519085
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Local Institution - 0366 Los Alamitos, California, United States
- Local Institution - 0272 San Diego, California, United States
- Local Institution - 0273 West Hollywood, California, United States
- Local Institution - 0381 Aurora, Colorado, United States
NCT05652335
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +22 more
- Locations
-
- City of Hope Duarte, California, United States
- City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
- University of California San Francisco San Francisco, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
NCT05927571
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
- Calvary Mater Newcastle Waratah, New South Wales, Australia
- Royal Adelaide Hospital;Haematology Clinical Trials Unit Adelaide, South Australia, Australia
- St. Vincent's Hospital Melbourne Melbourne, Victoria, Australia
NCT07018050
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, China
NCT07138209
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- National Clinical Research Center for Blood Diseases Tianjin, Tianjin Municipality, China
NCT06375044
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Mayo Clinic Florida Jacksonville, Florida, United States
- Dana Farber Cancer institution Boston, Massachusetts, United States
- Mayo Clinic Rochester Rochester, Minnesota, United States
NCT06574568
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Beijing Chao-yang Hospital, Capital Medical University Beijing, Beijing Municipality, China
- Beijing Jishuitan Hospital, Capital Medical University Beijing, Beijing Municipality, China
- Shunde Hospital of Southern Medical University Foshan, Guangdong, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma
NCT07369895
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
NCT07312188
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, China
NCT05565807
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Beijing Chao-Yang Hospital,Capital Medicine University Beijing, Beijing Municipality, China
- Peking university Third hospital Beijing, Beijing Municipality, China
- The first affiliated hospital ,Sun Yat-sen University Guangzhou, Guangdong, China
- The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China
NCT05913804
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China
NCT06232096
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital Beijing, China
NCT07728188
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- University of Arizona Cancer Center /ID# 285339 Tucson, Arizona, United States
- Toi Clinical Research - Whittier /ID# 284462 Cerritos, California, United States
- University of California Los Angeles /ID# 282444 Los Angeles, California, United States
- University Of Colorado - Anschutz Medical Campus /ID# 283478 Aurora, Colorado, United States
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
NCT07681596
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Research Site Duarte, California, United States
- Research Site Denver, Colorado, United States
- Research Site Tampa, Florida, United States
- Research Site Atlanta, Georgia, United States
NCT07623798
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- ZhongShan Hospital FuDan University Shanghai, Shanghai Municipality, China
Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy
NCT06825845
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
Not specified
A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma
NCT06500507
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China
To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple Myeloma
NCT06298266
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Guangdong Second Provincial General Hospital Guangzhou, Guangdong, China
Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet
NCT04191616
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Rocky Mountain Cancer Centers Denver Midtown Denver, Colorado, United States
- Yale Cancer Center New Haven, Connecticut, United States
- Affiliated Oncologists, LLC Chicago Ridge, Illinois, United States